Driving Medical Innovation with "GelART®" Next-Generation Regenerative Materials

Supporting Tissue Regeneration as a Structural Scaffold for Cells

Shibuya has obtained the "Eligibility Confirmation for Regenerative Medicine Materials" from the PMDA for its gelatin hydrogel particles, "GelART®" Developed through joint research with Kyoto University, this material enhances the natural healing and proliferative powers of cells by acting as a "scaffold" that supports their environment. As the world’s first clinical-grade biodegradable particle of its kind, it is expected to be applied to various treatments, including skin ulcers, hearing loss, and bone fractures.

Realizing Ideal Drug Delivery through Controlled Biodegradation

Beyond serving as a scaffold, "GelART®" possesses excellent characteristics as a Drug Delivery System (DDS) carrier for cancer treatments and hormone therapies. The medication is released gradually as the particles are decomposed by enzymes in the body, maximizing therapeutic effects. Since the material is metabolized into amino acids after decomposition, it has no adverse effects on the body. Shibuya continues to contribute to advanced medicine by providing total solutions that integrate sterilization, automation, and advanced material technology.